ATE248588T1 - Geschmacksmaskierte zubereitungen - Google Patents

Geschmacksmaskierte zubereitungen

Info

Publication number
ATE248588T1
ATE248588T1 AT00931481T AT00931481T ATE248588T1 AT E248588 T1 ATE248588 T1 AT E248588T1 AT 00931481 T AT00931481 T AT 00931481T AT 00931481 T AT00931481 T AT 00931481T AT E248588 T1 ATE248588 T1 AT E248588T1
Authority
AT
Austria
Prior art keywords
composition
masked
flavor
preparations
methacrylic acid
Prior art date
Application number
AT00931481T
Other languages
English (en)
Inventor
Gour Mukherji
Sandhya Goel
Vinod Kumar Arora
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IN867DE1999 external-priority patent/IN191239B/en
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Application granted granted Critical
Publication of ATE248588T1 publication Critical patent/ATE248588T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Seasonings (AREA)
AT00931481T 1999-06-11 2000-06-07 Geschmacksmaskierte zubereitungen ATE248588T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN867DE1999 IN191239B (de) 1999-06-11 1999-06-11
US09/587,535 US6565877B1 (en) 1999-06-11 2000-06-05 Taste masked compositions
PCT/IB2000/000765 WO2000076479A1 (en) 1999-06-11 2000-06-07 Taste masked compositions

Publications (1)

Publication Number Publication Date
ATE248588T1 true ATE248588T1 (de) 2003-09-15

Family

ID=26324681

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00931481T ATE248588T1 (de) 1999-06-11 2000-06-07 Geschmacksmaskierte zubereitungen

Country Status (13)

Country Link
EP (1) EP1194124B1 (de)
CN (1) CN1355692A (de)
AT (1) ATE248588T1 (de)
AU (1) AU4943000A (de)
BR (1) BR0011345A (de)
CZ (1) CZ20014379A3 (de)
DE (1) DE60005012T2 (de)
ES (1) ES2204605T3 (de)
HU (1) HUP0201307A2 (de)
PL (1) PL364801A1 (de)
PT (1) PT1194124E (de)
SK (1) SK18142001A3 (de)
WO (1) WO2000076479A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030011797A (ko) * 2000-03-28 2003-02-11 바이오케미 게젤샤프트 엠베하 맛이 차폐된 과립형 입자
ES2220789T3 (es) * 2000-10-30 2004-12-16 Lupin Limited Composicion de cefuroxima axetilo de liberacion lenta que se desintegra rapidamente.
DE60226012T2 (de) 2001-03-05 2009-05-14 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Geschmacksmaskierte pharmazeutische formulierungen
AU2002327418A1 (en) * 2001-08-01 2003-02-17 Bristol-Myers Squibb Company Taste masking composition
ES2201932B2 (es) * 2001-11-23 2005-03-16 Glaxo Group Limited Composicion farmaceutica.
TWI355276B (en) 2003-01-14 2012-01-01 Akira Tsuji Gastrointestinal absorption enhancer mediated by p
KR100552567B1 (ko) * 2003-08-23 2006-02-15 한국유나이티드제약 주식회사 수분 흡수에 안정하고 빠르게 붕해되는 세푸록심 악세틸을포함하는 정제의 조성물 및 제조 방법
WO2005055987A1 (en) * 2003-12-15 2005-06-23 Council Of Scientific & Industrial Research TASTE MASKED PHARMACEUTICAL COMPOSITIONS COMPRISING BITTER DRUG AND pH SENSITIVE POLYMER
CN1878540B (zh) * 2003-12-15 2012-02-29 科学与工业研究委员会 含pH敏感性聚合物的掩味的药物组合物
GB2419094A (en) 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
CN101502492B (zh) * 2009-03-13 2013-11-27 上海微丸医药开发有限公司 一种克拉霉素去苦味颗粒的制备方法
CN103239406B (zh) * 2012-02-01 2017-02-08 杭州赛利药物研究所有限公司 克拉霉素肠溶制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1322306A (en) * 1971-04-15 1973-07-04 Meiji Seika Co Stabilized antibiotic preparation and manufacturing process therefor
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US5175003A (en) * 1990-04-06 1992-12-29 Biosytes Usa, Inc. Dual mechanism controlled release system for drug dosage forms
US5919489A (en) * 1995-11-01 1999-07-06 Abbott Laboratories Process for aqueous granulation of clarithromycin
US5972389A (en) * 1996-09-19 1999-10-26 Depomed, Inc. Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
US5851579A (en) * 1996-10-28 1998-12-22 Eastman Chemical Company Aqueous enteric coating compositions

Also Published As

Publication number Publication date
ES2204605T3 (es) 2004-05-01
SK18142001A3 (sk) 2002-06-04
DE60005012D1 (de) 2003-10-09
CN1355692A (zh) 2002-06-26
PL364801A1 (en) 2004-12-13
WO2000076479A1 (en) 2000-12-21
HUP0201307A2 (hu) 2002-11-28
PT1194124E (pt) 2004-02-27
AU4943000A (en) 2001-01-02
EP1194124A1 (de) 2002-04-10
EP1194124B1 (de) 2003-09-03
CZ20014379A3 (cs) 2002-08-14
BR0011345A (pt) 2002-04-23
DE60005012T2 (de) 2004-07-08

Similar Documents

Publication Publication Date Title
ATE248588T1 (de) Geschmacksmaskierte zubereitungen
Wang et al. Prodrug approaches to the improved delivery of peptide drugs
BG103786A (bg) Състав и метод за профилактика и лечение на нiv и други инфекциозни заболявания при човека
CA2445276A1 (en) Aripiprazole oral solution
BR0210530A (pt) Composições farmacêuticas de drogas e poìimeros acìdicos neutralizados
DK1256343T3 (da) Flibanserin til behandlingen af extrapyramidale bevægelseslidelser
CA2282513A1 (en) Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations
ATE235895T1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
DK0524989T3 (da) Medikamentpræparat med reguleret frigivelse
NO20040268L (no) Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen
WO2001010456A3 (en) Peptides that block viral infectivity and methods of use thereof
WO2001087227A3 (en) Drug containing polymeric micelles
ATE513541T1 (de) Pharmazeutische zusammensetzungen zur oralen verabreichung von calcitonin
BR0213379A (pt) Formulação resistente a derramamento de mascaramento de gosto
CA2382013A1 (en) Pharmaceutical solutions of levosimendan
WO2006007354A3 (en) A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
BR9809708A (pt) Composições farmacêuticas de peptìdeos tendo solubilidade baixa em meio fisiológico
ATE286720T1 (de) Pharmazeutische formulierungen auf basis fester dispersionen
WO2001068676A3 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzeimittel
SE0001916D0 (sv) Novel formulation
RU93004785A (ru) Твердые капсулы окфосфата цитарабина
GB2384426A (en) Controlled release from copolymers of acrylic or methacrylic acid/l-dopa, acrylic or methacrylic acid/l-α-Methyl dopa, acrylic or methacrylic
WO2001028538A3 (en) Laxative preparation containing l-arginine
James Grapefruit juice and saquinavir
DE60024439D1 (de) Enalaprilmaleat enthaltende, stabile, feste arzneimittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1194124

Country of ref document: EP

REN Ceased due to non-payment of the annual fee